Records management and archiving in the pharmaceutical industry and regulatory authorities

被引:2
|
作者
Rajh, Arian [1 ]
机构
[1] Univ Zagreb, Fac Humanities & Social Sci, Dept Informat & Commun Sci, Zagreb, Croatia
关键词
Digital archives; dossiers on medicinal products; electronic common technical document; pharmaceutical industry; regulatory agencies; METS;
D O I
10.1080/23257962.2021.1873119
中图分类号
C [社会科学总论];
学科分类号
03 ; 0303 ;
摘要
This article describes the processes that take place in the pharmaceutical regulatory environment and documentation on medicinal products. Granting of marketing authorization and other regulatory processes use dossiers on medicinal products as their primary resources. The pharmaceutical industry moved from paper to digital marketing authorization dossiers. The article discusses the tasks of those responsible for managing documentation in the pharmaceutical industry and regulatory agencies. There are people with various job roles who work on the dossiers on medicinal products in the companies and agencies, but they are primarily focused on the content. In most pharmaceutical and regulatory organizations, medicinal products dossiers must be kept for the long term or permanently. Hence, records managers and archivists are most welcome to work in this milieu. In this respect, the article outlines the competencies necessary for managing digital records and dossiers on medicinal products. Finally, the article explores future trends in archiving pharmaceutical documentation and proposes necessary standards and mechanisms for the task, as well as the information model of submission and archival information packages for this domain.
引用
收藏
页码:79 / 94
页数:16
相关论文
共 50 条
  • [31] Electronic patient records: The pharmaceutical industry's requirements
    Hyde, A
    TOWARD AN ELECTRONIC PATIENT RECORD '98 CONFERENCE AND EXPOSITION, PROCEEDINGS - VOLS 1-3, 1998, : C86 - C89
  • [32] Electronic archiving and records management: State of the art of presentation of seven solutions
    Chebbi, Aida
    DOCUMENTATION ET BIBLIOTHEQUES, 2012, 58 (02): : 88 - 90
  • [33] Recent Regulatory Trends in Pharmaceutical Manufacturing and their Impact on the Industry
    Tabersky, Daniel
    Woelfle, Michael
    Ruess, Juan-Antonio
    Brem, Simon
    Brombacher, Stephan
    CHIMIA, 2018, 72 (03) : 146 - 150
  • [34] PAT and QbD in the regulatory environment of the pharmaceutical industry.
    Schmidt-Bader, Torsten
    CHEMIE INGENIEUR TECHNIK, 2010, 82 (04) : 415 - 428
  • [35] Pharmaceutical Industry: Regulatory Control and Impact on NMR Spectroscopy
    Ruggiero, Andrea
    Branch, Sarah K.
    EMAGRES, 2015, 4 (02): : 209 - 217
  • [36] DEVELOPING A DATABASE FOR AUTOMATING REGULATORY AFFAIRS IN THE PHARMACEUTICAL INDUSTRY
    Slevin, Lindi
    Shojanoori, Reza
    Juric, Radmila
    JOURNAL OF INTEGRATED DESIGN & PROCESS SCIENCE, 2005, 9 (04) : 1 - 11
  • [37] Recent EU Regulatory Law Developments for the Pharmaceutical Industry
    Chenesseau, Audrey
    Pavlou, Anna
    EUROPEAN JOURNAL OF RISK REGULATION, 2012, 3 (03) : 421 - 424
  • [38] QUALITY RISK MANAGEMENT IN THE PHARMACEUTICAL INDUSTRY
    Dimeny, Gabor
    Popescu, Sorin
    BUSINESS EXCELLENCE, 2006, : 129 - 134
  • [39] A Compliance Management System for the Pharmaceutical Industry
    Fisher, Julie
    Aldea, Arantza
    Banares-Alcantara, Rene
    18TH EUROPEAN SYMPOSIUM ON COMPUTER AIDED PROCESS ENGINEERING, 2008, 25 : 949 - 954
  • [40] Building Management Systems in the pharmaceutical industry
    Allison, M
    MEASUREMENT & CONTROL, 1997, 29 (10): : 300 - 303